G/TBT/N/KOR/933  
22 October 2020  
(20-7325) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  REPUBLIC OF KOREA   
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:  Ministry of Food and Drug Safety  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
Documents are available from the Ministry of Food and Drug safety website 
(www.mfds.go.kr ).  
Also available from:  
International Cooperation Office  
Ministry of Food and Drug Safety  
187 Osongsaengmyeong2 -ro, Osong -eup, Heungdoek -gu Cheongju -si, 
Chungcheongbuk -do, 28159  
Republic of Korea  
Tel: (+82) 43 719 -1564 
Fax: (+82) 43 -719-1550 
Email: intmfds@korea.kr  
3. Notified under Article 2.9.2 [   ], 2.10.1 [X], 5.6.2 [   ], 5.7.1 [   ], other :  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  
Pharmaceuticals  
5. Title, number of pages and language(s) of the notified document:  A draft revision 
of "Pharmaceutical Affairs Act" (4 page(s), in Korean)  
6. Description of content:  The Ministry of Food and Drug Safety of the Republic of Korea 
is partly revising the "Pharmaceutical Affairs Act". The main contents  are: 
• Organization of prohibited provision such as exaggerated pharmaceuticals 
advertisement (Article 68(4) of proposal)  
• It is prohibited to use documents or design hints abortion on the pharmaceuticals, 
however, allowed to provide exception for the artificial a bortion medicine 
according to Mother and Child Health Act.  
7. Objective and rationale, including the nature of urgent problems where 
applicable:  It is allowed to facilitate permission and utilization of pharmaceuticals within 
the acceptable range under Mo ther and Child Health Act by organizing the current 
provision forbids to use documents or design hints abortion on the pharmaceuticals 
following up on the constitutional court's conclusion in April 2019, which is abortion ban 
is unconstitutional.; Reducing  trade barriers and facilitating trade; Other  G/TBT/N/KOR/933  
 
- 2 - 
 
  8. Relevant documents:   
• Ministry of Food and Drug Safety Public Notice  No. 2020 -433 (6 Oct 2020)  
9. Proposed date of adoption:  To be determined  
Proposed date of entry into force:  To be determined  
10. Final date for comments:  40 days from notification  
11. Texts available from:  National enquiry point [X] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
Korea WTO TBT Enquiry Point  
Technical Barriers to Trade (TBT) Division  
Korean Agency for Technology and Standards (KATS)  
93 Isu -ro Maengdong -myeon Eumseong -gun 
Chungchungbuk -do  
27737  
+(82) 43 870 5525  
+(82) 43 870 5682 (Fax)  
tbt@korea.kr  
http://www.knowtbt.kr  
https://members.wto.org/crnattachments/2020/TBT/KOR/20_6344_00_x.pdf